HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of lymphocytes in percutaneous liver biopsy cores. Different T:B cell ratio in HB sAg-positive and -negative hepatitis.

Abstract
The lymphocytes infiltrating the liver were isolated and characterized as T or B cells in three groups of patients: 20 patients with hepatitis B surface antigen (HB sAg)-positive acute and chronic hepatitis, 8 patients with HBsAg-negative chronic hepatitis with prior evidence for hepatitis B virus (HBV) infection, and 5 patients with HBsAg-negative chronic hepatitis without prior evidence for HBV infection. The predominant cell infiltrating the liver was shown to be a T cell in all categories; however, the ratio of T:B cells was significantly lower (1.96) in the patients without evidence for HBV infection than in the patients who were HBsAg-positive at (7.86), or before (8.85) the time of study. The significantly (P less than 0.001) higher number of B cells in the patients with chronic hepatitis of unknown etiology suggests that a different immunopathogenetic mechanism is operative in this group. A peripheral T lymphocytopenia was observed in patients with both antecedent and existent HBs-antigenemia, but not in the patients without evidence for HBV infection.
AuthorsD J Miller, J M Dwyer, G Klatskin
JournalGastroenterology (Gastroenterology) Vol. 72 Issue 6 Pg. 1199-203 (Jun 1977) ISSN: 0016-5085 [Print] United States
PMID323096 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Topics
  • Acute Disease
  • Adult
  • Aged
  • B-Lymphocytes
  • Biopsy, Needle
  • Chronic Disease
  • Hepatitis (immunology, pathology)
  • Hepatitis B (immunology, pathology)
  • Humans
  • Immunologic Techniques
  • Leukocyte Count
  • Liver (pathology)
  • Middle Aged
  • T-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: